Oruka Therapeutics, Inc. (ORKA) Executive Compensation
Oruka Therapeutics, Inc. (ORKA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ORKA
CIK: 907654
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerMark DeCost
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-15 | 2026-10-15 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000907654-26-000108 | View SEC Doc Filr Page |
| 144 | 2026-10-15 | — | 144 Filing | 0001950047-26-010266 | View SEC Doc Filr Page |
| 4 | 2026-10-13 | 2026-10-12 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000907654-26-000106 | View SEC Doc Filr Page |
| 144 | 2026-10-13 | — | 144 Filing | 0001950047-26-010177 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000907654-26-000104 | View SEC Doc Filr Page |
| 144 | 2026-10-01 | — | 144 Filing | 0001950047-26-009940 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-21 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000907654-26-000102 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-21 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000907654-26-000100 | View SEC Doc Filr Page |
| 144 | 2026-09-21 | — | 144 Filing | 0001950047-26-009701 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-15 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000907654-26-000098 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000907654-26-000097 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-15 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000907654-26-000096 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-15 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000907654-26-000095 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-15 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000907654-26-000094 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-09-01 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000907654-26-000088 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-09-01 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000907654-26-000087 | View SEC Doc Filr Page |
| 144 | 2026-09-01 | — | 144 Filing | 0001950047-26-008954 | View SEC Doc Filr Page |
| 144 | 2026-09-01 | — | 144 Filing | 0001950047-26-008949 | View SEC Doc Filr Page |
| 424B5 | 2026-08-28 | — | PROSPECTUS | 0001213900-26-095041 | View SEC Doc Filr Page |
| EFFECT | 2026-08-27 | — | EFFECT Filing | 9999999995-26-002787 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-24 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000907654-26-000084 | View SEC Doc Filr Page |
| 3 | 2026-08-25 | 2026-08-24 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0000907654-26-000083 | View SEC Doc Filr Page |
| 8-K | 2026-08-24 | 2026-08-24 | CURRENT REPORT | 0001213900-26-093021 | View SEC Doc Filr Page |
| S-3 | 2026-08-21 | — | REGISTRATION STATEMENT | 0001213900-26-092612 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-17 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000907654-26-000079 | View SEC Doc Filr Page |